# Amtech Systems Inc: financial statements, quarterly

ASYS · Nasdaq · CIK 720500 · [Industrials](/sectors/industrials.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/asys.md) · [Financials](/companies/asys/financials.md) · [Filings](/companies/asys/filings.md) · [Insiders](/companies/asys/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/asys/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [27.7 d](/filings/0000950170-24-135825.md) | [24.9](/filings/0000950170-25-014465.md) | [25.4](/filings/0000950170-25-069135.md) | [26.7](/filings/0000950170-25-104002.md) | [24.1 d](/filings/0001193125-25-314147.md) | [24.4](/filings/0001193125-26-039360.md) | [15.6](/filings/0001193125-26-211854.md) | [19.6](/filings/0000720500-26-000010.md) | [19.8 d](/filings/0001193125-25-314147.md) | [19.0](/filings/0001193125-26-039360.md) | [20.5](/filings/0001193125-26-211854.md) | [22.4](/filings/0000720500-26-000010.md) |
| Cost of revenue | $m | [20.3 d](/filings/0000950170-24-135825.md) | [15.9](/filings/0000950170-25-014465.md) | [17.0](/filings/0000950170-25-069135.md) | [17.0](/filings/0000950170-25-104002.md) | [14.3 d](/filings/0001193125-25-314147.md) | [15.0](/filings/0001193125-26-039360.md) | [15.9](/filings/0001193125-26-211854.md) | [10.4](/filings/0000720500-26-000010.md) | [11.0 d](/filings/0001193125-25-314147.md) | [10.5](/filings/0001193125-26-039360.md) | [10.7](/filings/0001193125-26-211854.md) | [11.2](/filings/0000720500-26-000010.md) |
| Gross profit | $m | [2.8 d](/filings/0000950170-24-135825.md) | [8.2](/filings/0000950170-25-014465.md) | [8.5](/filings/0000950170-25-069135.md) | [9.8](/filings/0000950170-25-104002.md) | [9.8 d](/filings/0001193125-25-314147.md) | [9.4](/filings/0001193125-26-039360.md) | [(0.3)](/filings/0001193125-26-211854.md) | [9.1](/filings/0000720500-26-000010.md) | [8.8 d](/filings/0001193125-25-314147.md) | [8.5](/filings/0001193125-26-039360.md) | [9.8](/filings/0001193125-26-211854.md) | [11.2](/filings/0000720500-26-000010.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [11.1 d](/filings/0000950170-24-135825.md) | [8.6](/filings/0000950170-25-014465.md) | [8.3](/filings/0000950170-25-069135.md) | [8.2](/filings/0000950170-25-104002.md) | [8.8 d](/filings/0001193125-25-314147.md) | [8.1](/filings/0001193125-26-039360.md) | [7.1](/filings/0001193125-26-211854.md) | [7.4](/filings/0000720500-26-000010.md) | [6.4 d](/filings/0001193125-25-314147.md) | [6.9](/filings/0001193125-26-039360.md) | [7.2](/filings/0001193125-26-211854.md) | [8.0](/filings/0000720500-26-000010.md) |
| Operating income | $m | [(11.7) d](/filings/0000950170-24-135825.md) | [(8.9)](/filings/0000950170-25-014465.md) | [1.4](/filings/0000950170-25-069135.md) | [0.8](/filings/0000950170-25-104002.md) | [0.0 d](/filings/0001193125-25-314147.md) | [0.3](/filings/0001193125-26-039360.md) | [(31.6)](/filings/0001193125-26-211854.md) | [0.9](/filings/0000720500-26-000010.md) | [1.8 d](/filings/0001193125-25-314147.md) | [0.8](/filings/0001193125-26-039360.md) | [1.8](/filings/0001193125-26-211854.md) | [2.2](/filings/0000720500-26-000010.md) |
| Interest expense | $m | [0.2 d](/filings/0000950170-24-135825.md) | [0.2](/filings/0000950170-25-014465.md) | [0.2](/filings/0000950170-25-069135.md) | [0.1](/filings/0000950170-25-104002.md) | [0.1 d](/filings/0001193125-25-314147.md) | [0.0](/filings/0001193125-26-039360.md) | [0.0](/filings/0001193125-26-211854.md) | [0.0](/filings/0000720500-26-000010.md) | [0.0 d](/filings/0001193125-25-314147.md) | [0.0](/filings/0001193125-26-039360.md) | [0.0](/filings/0001193125-26-211854.md) | [0.0](/filings/0000720500-26-000010.md) |
| Income tax | $m | [0.1 d](/filings/0000950170-24-135825.md) | [0.1](/filings/0000950170-25-014465.md) | [0.2](/filings/0000950170-25-069135.md) | [0.5](/filings/0000950170-25-104002.md) | [0.2 d](/filings/0001193125-25-314147.md) | [0.4](/filings/0001193125-26-039360.md) | [0.3](/filings/0001193125-26-211854.md) | [0.8](/filings/0000720500-26-000010.md) | [0.8 d](/filings/0001193125-25-314147.md) | [0.6](/filings/0001193125-26-039360.md) | [0.5](/filings/0001193125-26-211854.md) | [0.6](/filings/0000720500-26-000010.md) |
| Net income | $m | [(12.0) d](/filings/0000950170-24-135825.md) | [(9.4)](/filings/0000950170-25-014465.md) | [1.0](/filings/0000950170-25-069135.md) | [0.4](/filings/0000950170-25-104002.md) | [(0.5) d](/filings/0001193125-25-314147.md) | [0.3](/filings/0001193125-26-039360.md) | [(31.8)](/filings/0001193125-26-211854.md) | [0.1](/filings/0000720500-26-000010.md) | [1.1 d](/filings/0001193125-25-314147.md) | [0.1](/filings/0001193125-26-039360.md) | [1.2](/filings/0001193125-26-211854.md) | [1.7](/filings/0000720500-26-000010.md) |
| Diluted EPS | $ per share | not reported | [(0.66)](/filings/0000950170-25-014465.md) | [0.07](/filings/0000950170-25-069135.md) | [0.03](/filings/0000950170-25-104002.md) | not reported | [0.02](/filings/0001193125-26-039360.md) | [(2.23)](/filings/0001193125-26-211854.md) | [0.01](/filings/0000720500-26-000010.md) | not reported | [0.01](/filings/0001193125-26-039360.md) | [0.08](/filings/0001193125-26-211854.md) | [0.10](/filings/0000720500-26-000010.md) |
| Basic EPS | $ per share | not reported | [(0.66)](/filings/0000950170-25-014465.md) | [0.07](/filings/0000950170-25-069135.md) | [0.03](/filings/0000950170-25-104002.md) | not reported | [0.02](/filings/0001193125-26-039360.md) | [(2.23)](/filings/0001193125-26-211854.md) | [0.01](/filings/0000720500-26-000010.md) | not reported | [0.01](/filings/0001193125-26-039360.md) | [0.08](/filings/0001193125-26-211854.md) | [0.11](/filings/0000720500-26-000010.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [13.1](/filings/0000950170-24-135825.md) | [17.0](/filings/0000950170-24-013277.md) | [13.0](/filings/0000950170-24-055725.md) | [13.2](/filings/0000950170-24-092822.md) | [11.1](/filings/0001193125-25-314147.md) | [13.2](/filings/0000950170-25-014465.md) | [13.4](/filings/0000950170-25-069135.md) | [15.6](/filings/0000950170-25-104002.md) | [17.9](/filings/0000720500-26-000010.md) | [22.1](/filings/0001193125-26-039360.md) | [24.4](/filings/0001193125-26-211854.md) | [83.1](/filings/0000720500-26-000010.md) |
| Current assets | $m | [81.2](/filings/0000950170-24-135825.md) | [78.2](/filings/0000950170-24-013277.md) | [70.3](/filings/0000950170-24-055725.md) | [70.4](/filings/0000950170-24-092822.md) | [64.7](/filings/0001193125-25-314147.md) | [64.3](/filings/0000950170-25-014465.md) | [54.1](/filings/0000950170-25-069135.md) | [57.8](/filings/0000950170-25-104002.md) | [60.2](/filings/0000720500-26-000010.md) | [62.4](/filings/0001193125-26-039360.md) | [66.5](/filings/0001193125-26-211854.md) | [128](/filings/0000720500-26-000010.md) |
| Total assets | $m | [137](/filings/0000950170-24-135825.md) | [125](/filings/0000950170-24-013277.md) | [116](/filings/0000950170-24-055725.md) | [127](/filings/0000950170-24-092822.md) | [119](/filings/0001193125-25-314147.md) | [118](/filings/0000950170-25-014465.md) | [83.4](/filings/0000950170-25-069135.md) | [89.5](/filings/0000950170-25-104002.md) | [92.9](/filings/0000720500-26-000010.md) | [94.1](/filings/0001193125-26-039360.md) | [97.4](/filings/0001193125-26-211854.md) | [157](/filings/0000720500-26-000010.md) |
| Current liabilities | $m | [29.7](/filings/0000950170-24-135825.md) | [26.2](/filings/0000950170-24-013277.md) | [25.9](/filings/0000950170-24-055725.md) | [27.4](/filings/0000950170-24-092822.md) | [20.2](/filings/0001193125-25-314147.md) | [19.0](/filings/0000950170-25-014465.md) | [16.7](/filings/0000950170-25-069135.md) | [18.8](/filings/0000950170-25-104002.md) | [20.5](/filings/0000720500-26-000010.md) | [21.5](/filings/0001193125-26-039360.md) | [23.2](/filings/0001193125-26-211854.md) | [23.6](/filings/0000720500-26-000010.md) |
| Total liabilities | $m | [48.7](/filings/0000950170-24-135825.md) | [45.4](/filings/0000950170-24-013277.md) | [35.6](/filings/0000950170-24-055725.md) | [45.3](/filings/0000950170-24-092822.md) | [37.0](/filings/0001193125-25-314147.md) | [35.3](/filings/0000950170-25-014465.md) | [32.4](/filings/0000950170-25-069135.md) | [37.7](/filings/0000950170-25-104002.md) | [39.5](/filings/0000720500-26-000010.md) | [40.0](/filings/0001193125-26-039360.md) | [41.4](/filings/0001193125-26-211854.md) | [41.1](/filings/0000720500-26-000010.md) |
| Long-term debt | $m | [10.7](/filings/0000950170-23-070422.md) | not reported | not reported | not reported | [0.3](/filings/0000950170-24-135825.md) | not reported | not reported | not reported | [0.3](/filings/0001193125-25-314147.md) | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [88.4](/filings/0000950170-24-135825.md) | [79.6](/filings/0000950170-24-013277.md) | [80.9](/filings/0000950170-24-055725.md) | [81.7](/filings/0000950170-24-092822.md) | [82.4](/filings/0001193125-25-314147.md) | [82.4](/filings/0000950170-25-014465.md) | [51.0](/filings/0000950170-25-069135.md) | [51.7](/filings/0000950170-25-104002.md) | [53.4](/filings/0000720500-26-000010.md) | [54.1](/filings/0001193125-26-039360.md) | [56.0](/filings/0001193125-26-211854.md) | [116](/filings/0000720500-26-000010.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(551) d](/filings/0000950170-24-135825.md) | [4,971](/filings/0000950170-25-014465.md) | [336 d](/filings/0000950170-25-069135.md) | [3,656 d](/filings/0000950170-25-104002.md) | [879 d](/filings/0001193125-25-314147.md) | [2,867](/filings/0001193125-26-039360.md) | [210 d](/filings/0001193125-26-211854.md) | [2,532 d](/filings/0000720500-26-000010.md) | [2,268 d](/filings/0001193125-25-314147.md) | [4,103](/filings/0001193125-26-039360.md) | [2,093 d](/filings/0001193125-26-211854.md) | [1,120 d](/filings/0000720500-26-000010.md) |
| Capital expenditure | $k | [976 d](/filings/0000950170-24-135825.md) | [756](/filings/0000950170-25-014465.md) | [1,220 d](/filings/0000950170-25-069135.md) | [3,334 d](/filings/0000950170-25-104002.md) | [(432) d](/filings/0001193125-25-314147.md) | [143](/filings/0001193125-26-039360.md) | [9.0 d](/filings/0001193125-26-211854.md) | [552 d](/filings/0000720500-26-000010.md) | [246 d](/filings/0001193125-25-314147.md) | [277](/filings/0001193125-26-039360.md) | [198 d](/filings/0001193125-26-211854.md) | [126 d](/filings/0000720500-26-000010.md) |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [14.0](/filings/0000950170-24-013277.md) | [14.2](/filings/0000950170-24-055725.md) | [14.1](/filings/0000950170-24-092822.md) | [14.2](/filings/0000950170-25-014465.md) | [14.2](/filings/0000950170-25-069135.md) | [14.3](/filings/0000950170-25-104002.md) | [14.3](/filings/0001193125-26-039360.md) | [14.3](/filings/0001193125-26-211854.md) | [14.3](/filings/0000720500-26-000010.md) | [14.7](/filings/0001193125-26-039360.md) | [14.9](/filings/0001193125-26-211854.md) | [16.0](/filings/0000720500-26-000010.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 17,508,101 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0000720500-26-000010.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.